Research

“Neuro-diverse: A Symposium on Autism, Neuroscience and Perceptual Thinking” and an associated evening lecture – both free and open to the public – will take place on the Vanderbilt campus Monday, May 23.

Smoking is deleterious to health, but smokers who prefer menthol cigarettes to nonmenthol can breathe a sigh of relief…for now.

Collybolide – a natural product isolated from a mushroom – is a promising candidate for the development of non-addictive pain medicines.

It is widely assumed that individuals with autism spectrum disorder (ASD) are insensitive to pain due to the wide prevalence of self-injurious behaviors. A new study at Vanderbilt University Medical Center suggests that this may not be true.

COX-2 inhibitors – used clinically to reduce inflammation and pain – may find new applications for treating PTSD and other stress-related psychiatric disorders like major depression.

A national search will be launched this fall for the Barlow Family Director of the Vanderbilt Brain Institute, Provost and Vice Chancellor for Academic Affairs Susan R. Wente announced today. Current VBI Associate Director Ron Emeson will begin a term as interim director effective July 1.

The primary method used to test compounds for anti-cancer activity in cells is flawed, Vanderbilt University researchers reported May 2 in Nature Methods.